Kit Label: Anti-FITC-AP CISH Accessory Kit (Dako Omnis), Box A REF K589911-2 Anti-FITC-AP CISH ...
FDA Device Recall #Z-1384-2022 — Class III — May 20, 2022
Recall Summary
| Recall Number | Z-1384-2022 |
| Classification | Class III — Low risk |
| Date Initiated | May 20, 2022 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Agilent Technologies, Inc. |
| Location | Santa Clara, CA |
| Product Type | Devices |
| Quantity | 63 kits |
Product Description
Kit Label: Anti-FITC-AP CISH Accessory Kit (Dako Omnis), Box A REF K589911-2 Anti-FITC-AP CISH Accessory Kit (Dako Omnis), Box A REF K589911-21 Vial Labels: Mat. No K589911-21512
Reason for Recall
Label provided for substrate vail contained incorrect expiration date.
Distribution Pattern
U.S. Nationwide distribution in the states of NY and VA.
Lot / Code Information
Kit Model Number: K589911-2 UDI-DI Code for Kit: 0 5700571 11286 1 Lot Numbers: 06586309; 06646626; Vial Material Number: K859911-21512 Lot Number: 06646739 Lot Number: 06586327
Other Recalls from Agilent Technologies, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1544-2025 | Class II | GenetiSure Dx Labeling Kit, REF: K1201-64105, c... | Mar 20, 2025 |
| Z-2359-2019 | Class II | MassHunter Quantitative Analysis Software, Vers... | Aug 15, 2018 |
| Z-1737-2017 | Class II | Bond Elut OMS (Dried Matrix Spotting)' Product;... | Jun 17, 2015 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.